Loading...

ABCL ABCELLERA BIOLOGICS INC Expansion Plans 8-K Filing

BCLL

BCL

ABCELLERA BIOLOGICS INC

(ABCL)

2026 8-K

Earnings Announcement

Clinical Trial Update

Patent Settlement

Earnings Report

New CMO Appointment

Financial Statements

Clinical Trials

Clinical Trials

Regulatory Compliance

Financial Statements

Earnings Results

Management Change

Earnings Announcement

Earnings Reports

Annual Meeting of Shareholders

Departure of Directors

Financial Results Announcement

Workforce Reduction

Ownership of Antibody Drug ...

Annual Meeting of Shareholders

Investment Agreement

Regulation FD Disclosure

External Links:

On January 12, 2026, AbCellera Biologics Inc. announced that the first patients have been dosed in the Phase 2 portion of its clinical trial for ABCL635. This is a significant event for the company as it advances its development pipeline.

AI Assistant

ABCELLERA BIOLOGICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.